Rene Haas was on an exercise bike two weeks ago watching CNBC like he does every morning, when the tech sector took a beating. The TV screen had “red everywhere”, recalls the chief executive of Arm ...

AbbVie is a resurging Dividend King. Amgen's recent clinical setback makes its stock available at a discount. Gilead Sciences ...